Authors: REMOND G PORTEVIN B BONNET J CANET E REGOLI D DENANTEUIL G

Citation: G. Remond et al., PHARMACOLOGICAL PROFILE OF A NOVEL SERIES OF NK1 ANTAGONISTS - IN-VITRO AND IN-VIVO POTENCY OF BENZIMIDAZOLONE DERIVATIVES, European journal of medicinal chemistry, 32(11), 1997, pp. 843-868

Authors: PORTEVIN B LONCHAMPT M CANET E DENANTEUIL G

Citation: B. Portevin et al., DUAL INHIBITION OF HUMAN-LEUKOCYTE ELASTASE AND LIPID-PEROXIDATION - IN-VITRO AND IN-VIVO ACTIVITIES OF AZABICYCLO[2.2.2]OCTANE AND PERHYDROINDOLE DERIVATIVES, Journal of medicinal chemistry, 40(12), 1997, pp. 1906-1918

Authors: MORAIN P ABRAHAM C PORTEVIN B DENANTEUIL G

Citation: P. Morain et al., BIGUANIDE DERIVATIVES - AGONIST PHARMACOLOGY AT 5-HYDROXYTRYPTAMINE TYPE-3 RECEPTORS IN-VITRO, Molecular pharmacology, 46(4), 1994, pp. 732-742

Authors: COLLET JP DUCRUET T KRAMER MS HAGGERTY J FLORET D CHOMEL JJ DURR F AYMAND M HONEGGER D GILLET J DEGUERRY M LAMY D MAUOUIT A CHAIZE MA FONVIEILLE AM PORTEVIN B DUCHIN MJ

Citation: Jp. Collet et al., STIMULATION OF NONSPECIFIC IMMUNITY TO REDUCE THE RISK OF RECURRENT INFECTIONS IN CHILDREN ATTENDING DAY-CARE-CENTERS, The Pediatric infectious disease journal, 12(8), 1993, pp. 648-652

Authors: KRAUSBERTHIER L REMOND G VISALLI M HENO D PORTEVIN B VINCENT M

Citation: L. Krausberthier et al., IN-VIVO IMMUNOPHARMACOLOGICAL PROPERTIES OF TUFTSIN AND 4 ANALOGS, Immunopharmacology, 25(3), 1993, pp. 261-267